Anchora Medical announces closing of a $4.5M financing round led by HOYA Corporation

Anchora Medical is developing a single-use suturing device for the approximation of soft tissue during Minimally Invasive Surgery (MIS)

Anchora Medical, a portfolio company of Alon Medtech Ventures, announced today closing of a $4.5 million financing round led by HOYA Corporation (ADR: HOCPY, TYO: 7741), a key strategic investor, and Tal Capital. The funds will be used to complete Anchora's family of single-use laparoscopic suturing devices.

HOYA, a global medical device and high technology company, and Tal Capital, a US-based hi-tech investment company, join current investors Alon Medtech and Dr. Shimon Eckhouse in their support of the company.

Anchora’s single-use suturing device for the approximation of soft tissue during MIS incorporates tiny stainless-steel smart anchors threaded on a surgical thread to create either running or interrupted sutures in tissue.

"The recent investment, led by HOYA, is a robust validation of our technology, and it will allow us to move toward commercialization," said Yoni Epstein, Anchora CEO. "It is an honor to have such a global leader joining our team."

Dr. Shimon Eckhouse, Anchora’s Chairman, adds: “This partnership with HOYA is an excellent indication of the innovation and significance of Anchora's solution for the advancement of modern surgical technologies. We are confident that HOYA's leadership position in the global minimally-invasive surgical market will play a critical role in bringing Anchora’s exciting technology to surgeons and patients around the world.”

“Our investment in Anchora further complements HOYA’s aim of partnering with innovative minimally-invasive surgical companies to complement our Life Care medical device divisions. We are excited about the progress and novel advancements that Anchora has made with its laparoscopic suturing products. Timothy Gehlmann, President and CEO of HOYA’s Microline Surgical division, has joined Anchora as a board member and we look forward to the company’s continued successes. Additionally, we welcome the opportunity to continue our venture capital partnering activities with the flourishing medical device industry in Israel,” said Augustine Yee, HOYA’s Chief Legal Officer and Global Head of Corporate Development and Affairs.